Normal and abnormal consequences of apoptosis in the human heart: From postnatal morphogenesis to paroxysmal arrhythmias

Circulation

Volumn 90, Issue 1, 1994, Pages 556-573

  James, Thomas N ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLLAGEN;

ADULT; APOPTOSIS; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOMYOPATHY; DIAGNOSIS; FETUS; FIBROMUSCULAR DYSPLASIA; HEART; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART AUTOMATICITY; HEART BLOCK; HEART PACING; HIS BUNDLE; HUMAN; LONG QT SYNDROME; MICROSCOPY; MORPHOGENESIS; NEWBORN; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SINUS NODE; SUDDEN INFANT DEATH SYNDROME; TUNICA MEDIA; WOLFF PARKINSON WHITE SYNDROME;

EID: 0028334555     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.90.1.556     Document Type: Review

References (119)

1. Glucksmann A. Cell deaths in normal vertebrate ontogeny. Biol Revs Camb Philos Soc. 1950;26:59-86.
2. Saunders JW Jr. Death in embryonic systems: death in cells is the usual accompaniment of embryonic growth and differentiation. Science. 1966;154:604-612.
3. Kerr JRF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
4. Evan GI, Littlewood TD. The role of c-myc in cell growth. Curr Opin Genet Dev. 1993;3:44-49.
5. Eastman A, Barry MA. The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? Cancer Invest. 1992;10:229-240.
6. Askew DS, Ihle JN, Cleveland JL. Activation of apoptosis associated with enforced myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood. 1993;82:2079-2087.
7. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet. 1993; 341:1251-1254.
8. Searle J, Kerr JFR, Bishop CJ. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu. 1982;17:229-259.
9. Wyllie AH. Apoptosis: cell death under homeostatic control. Arch Toxicol. 1987;11:3-10.
10. Wyllie AH. Apoptosis: cell death in tissue regulation. J Pathol. 1987;153:313-316.
11. Gerschenson LE, Rotello RJ. Apoptosis: a different type of cell death. FASEB J. 1992;6:2450-2455.
12. Ellis RE, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol. 1991;7:663-698.
13. Alison MR, Sarraf CE. Apoptosis: a gene-directed programme of cell death. J R Coll Physicians Lond. 1992;26:25-35.
14. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 1991;32:223-254.
15. Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res. 1990; 10:1153-1160.
16. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;69:119-128.
17. Lennon SV, Martin SJ, Cotter TG. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. 1991;24:203-214.
18. Debatin K-M, Goldman CK, Waldmann TA, Krammer PH. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood. 1993;81:2972-2977.
19. Kerr JRF, Searle J, Hamon BV, Bishop CI. Apoptosis. In: Potten CS, ed. Perspectives in Mammalian Cell Death. New York, NY: Oxford University Press; 1987:93-128.
20. Macklis RM, Lin JY, Beresford B, Atcher RW, Hines JJ, Humm JL. Cellular kinetics, dosimetry, and radiobiology of α-particle radioimmunotherapy: induction of apoptosis. Radiat Res. 1992; 130:220-226.
21. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell. 1991;65:1097-1098.
22. Wright SC, Zhong J, Zheng H, Larrick JW. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J. 1993;7: 1045-1051.
23. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood. 1993;81: 151-157.
24. Bursch W, Liehr JG, Sirbasku DA, Putz B, Taper H, Schulte-Hermann R. Control of cell death (apoptosis) by diethylstilbestrol in an estrogen-dependent kidney tumor. Carcinogenesis. 1991;12: 855-860.
25. Fuchs BA, Pruett SB. Morphine induces apoptosis in murine thymocytes "in vivo" but not "in vitro": involvement of both opiate and glucocortico receptors. J Pharmacol Exp Ther. 1993; 266:417-423.
26. Grogg D, Hahn S, Erb HCD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC) III. CD4+ cytotoxic T cells induce apoptosis of APC. Eur J Immunol. 1992;22:267-272.
27. Golstein P, Ojcius DM, Young JD-E. Cell death mechanisms and the immune system. Immunol Revs. 1991;121:29-65.
28. Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology. 1985;56:351-358.
29. Cohen JJ. Programmed cell death in the immune system. Adv Immunol. 1991;50:55-85.
30. Buchman TG, Abello PA, Smith EH, Bulkley GB. Induction of heat shock response leads to apoptosis in endothelial cells previously exposed to endotoxin. Am J Physiol. 1993;34(Heart Circ Physiol):H165-H170.
31. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol. 1992;148:3543-3549.
32. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. 1993;328: 327-335.
33. James TN. Sudden death in babies: new observations in the heart. Am J Cardiol. 1968;22:479-506.
34. Valdes-Dapena MA, Greene M, Basavanand N, Catherman R, Truex RC. The myocardial conduction system in sudden death in infancy. N Engl J Med. 1973;289:1179-1180.
35. Anderson RH, Bouton J, Burrow CT, Smith A. Sudden death in infancy: a study of cardiac specialized tissue. Br Med J. 1974;2: 135-139.
36. Hackel DB, Reimer KA. Sudden Death: Cardiac and Other Causes. Durham, NC: Carolina Academic Press; 1993:72.
37. James TN. Cardiac conduction system: fetal and postnatal development. Am J Cardiol. 1970;25:213-226.
38. James TN. The sinus node. Am J Cardiol. 1977;40:965-986.
39. James TN. Anatomy of the Coronary Arteries. Hagerstown, Md: Harper Borthers; 1961.
40. James TN. The delivery and distribution of coronary collateral circulation. Chest. 1970;58:183-203.
41. James TN, Sherf L, Fine G, Morales AR. Comparative ultrastructure of the sinus node in man and dog. Circulation. 1966;34: 139-163.
42. Woods WT, Urthaler F, James TN. Spontaneous action potentials of cells in the canine sinus node. Circ Res. 1976;39:76-82.
43. James TN, Isobe JH, Urthaler F. Correlative electrophysiological and anatomical studies concerning the site of origin of escape rhythm during complete atrioventricular block in the dog. Circ Res. 1979;45:108-119.
44. Sherf L, James TN, Woods WT. Function of the atrioventricular node considered on the basis of observed histology and fine structure. J Am Coll Cardiol. 1985;5:770-780.
45. James TN. The connecting pathways between the sinus node and AV node and between the right and left atrium in the human heart. Am Heart J. 1963;66:498-508.
46. Lin CQ, Bissell MJ. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 1993;7:737-743.
47. James TN, Terasaki F, Pavlovich ER, Vikhert AM. Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long QT syndrome. J Lab Clin Med. 1993;122:309-323.
48. Pavlovich EP, Vikhert AM, Bokeriya LA, Kruglyakov IV. Ultrastructure of the sinoauricular region of the heart in the long QT syndrome [in Russian]. Arch Pathol. 1989;51:25-32.
49. Keith A, Flack MW. The auriculo-ventricular bundle of the human heart. Lancet. 1906;2:359-364.
50. James TN. Normal and abnormal variations in anatomy of the atrioventricular node and His bundle and their relevance to the pathogenesis of reentrant tachycardias and parasystolic rhythms. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology and Arrhythmias. New York, NY: Grune & Stratton; 1985;301-310.
51. James TN. Automaticity in the atrioventricular junction. In: Rosen MR, Janse MJ, Wit AL, eds. Cardiac Electrophysiology: A Textbook. Mt Kisco, NY: Futura Publishing Company; 1990; 191-122.
52. Lee KKH, Chan WY, Sze LY. Histogenetic potential of rat hind-limb interdigital tissues prior to and during the onset of programmed cell death. Anat Rec. 1993;236:568-572.
53. James TN. Anatomy of the sinus node, AV node and os cordis of the beef heart. Anat Rec. 1965;153:361-371.
54. James TN, Drake EH. Sudden death in Doberman Pinschers. Ann Intern Med. 1968;68:821-829.
55. James TN, Marshall TK. De subitaneis mortibus: XVIII. Persistent fetal dispersion of the atrioventricular node and His bundle within central fibrous body. Circulation. 1976;53: 1026-1034.
56. Lev M, Leffler WB, Langendorf R, Pick A. Anatomic findings in a case of ventricular pre-excitation (WPW) terminating in complete atrioventricular block. Circulation. 1966;34:718-733.
57. Brechenmacher C. Atrio-His bundle tracts. Br Heart J. 1975;37: 853-855.
58. James TN. Structure and function of the AV junction: the Mikamo Lecture of 1982. Jpn Circ J. 1983;47:1-47.
59. James TN, Puech P. De subitaneis mortibus: IX. Type A Wolff-Parkinson-White syndrome. Circulation. 1974;50:1264-1280.
60. Lewis T. Angina pectoris associated with high blood pressure and its relief by amyl nitrite; with a note on Nothnagel's syndrome. Heart. 1931;15:305-327.
61. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
62. Bokeriya LA, Belokon NA, Buziashvili YI, et al. The current approach to the surgical treatment of Jervell and Lange-Nielsen syndrome [in Russian]. Kardiolgiia. 1988;28:105-106.
63. Crawford MH, Karliner JS, O'Rourke RA, Friedman WF. Prolonged QT interval syndrome: successful treatment with combined ventricular pacing and propranolol. Chest. 1975;68: 369-373.
64. Eldar M, Griffin JC, Van Hare GF, et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol. 1992;20: 830-837.
65. Furman S. Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in artificial ventricular pacing. Circulation. 1992;85:843-844.
66. Zehender M, Buchner C, Meinertz T, Just H. Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in unipolar single-chamber ventricular pacing. Circulation. 1992;85:596-605.
67. Fraser GR, Froggatt P, James TN. Congenital deafness associated with electrocardiographic abnormalities, fainting attacks and sudden death: a recessive syndrome. Q J Med. 1964;33: 361-385.
68. James TN. Congenital deafness and cardiac arrhythmias. Am J Cardiol. 1967;19:627-643.
69. Bharati S, Dreifus L, Bucheleres G, Molthan M, Covitz W, Isenberg HS, Lev M. The conduction system in patients with a prolonged QT interval. J Am Coll Cardiol 1985;6:1110-1119.
70. Pellegrino A, Ho SY, Anderson RH, Hegerty A, Godman MJ, Michaelsson M. Prolonged QT interval and the cardiac conduction tissues. Am J Cardiol. 1986;58:1112-1113.
71. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome and the Harvey "ras-1" gene. Science. 1991;252: 704-706.
72. Keating M. Linkage analysis and long QT syndrome. Using genetics to study cardiovascular disease. Circulation. 1992;85: 1973-1986.
73. Engle MA. Wolff-Parkinson-White syndrome in infants and children. Am J Dis Child. 1952;84:692-705.
74. James TN. Robertson BT, Waldo AL, Branch CE. De subitaneis mortibus: XV. Hereditary stenosis of the His bundle in pug dogs. Circulation. 1975;52:1152-1160.
75. James TN, Spencer MS, Kloepfer JC. De subitaneis mortibus: XXI. Adult onset syncope, with comments on the nature of congenital heart block and the morphogenesis of the human atrioventricular septal junction. Circulation. 1976;54:1001-1009.
76. James TN, Galakhov I. De subitaneis mortibus: XXVI. Fatal electrical instability of the heart associated with benign congenital polycystic tumor of the atrioventricular node. Circulation. 1977;56:667-678.
77. Burke AP, Anderson PG, Virmani R, James TN, Herrera GA, Ceballos R. Tumors of the atrioventricular region: a clinical and immunohistochemical study. Arch Pathol Lab Med. 1991;114: 1057-1062.
78. Bredt H. Die primäre Erkrankung der Lungenschlagader in ihren verschiedenen Formen. Virch Arch Pathol Anat Physiol Klin Med. 1932;284:126-153.
79. James TN. On the cause of syncope and sudden death in primary pulmonary hypertension. Ann Intern Med. 1962;56:252-264.
80. James TN. Observations on the cardiovascular involvement, including the cardiac conduction system, in progressive muscular dystrophy. Am Heart J. 1962;63:48-56.
81. James TN, Frame B, Schatz IJ. Pathology of cardiac conduction system in Marfan's syndrome. Arch Intern Med. 1964;114:339-343.
82. Araki S, Shimada Y, Kaji K, Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun. 1990;168:1194-1200.
83. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells "in vitro." Am J Pathol. 1991;138: 447-453.
84. Thorball N, Moe H, Winther-Nielsen H. Progressive involution and physiological death of smooth muscle cells of rat incisai arterioles. Blood Vess. 1985;22:157-171.
85. Weissberg PL, Grainger DJ, Shanahan CM, Metcalfe JC. Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation. Cardiovasc Res. 1993;27: 1191-1198.
86. Hunt JC, Harrison EG Jr, Kincaid OW, Bernatz PE, Davis GD. Idiopathic fibrous and fibromuscular stenoses of the renal arteries associated with hypertension. Proc Staff Meet Mayo Clin. 1962;37: 181-216.
87. Harrison EG Jr, Hunt JC, Bernatz PE. Morphology of fibromuscular dysplasia of the renal artery in renovascular hypertension. Am J Med. 1967;43:97-112.
88. Connett MC, Lansche JM. Fibromuscular hyperplasia of the internal carotid artery. Ann Surg. 1965;162:59-62.
89. Meacham PW, Brantley B. Familial fibromuscular dysplasia of the mesenteric arteries. Southern Med J. 1987;80:1311-1316.
90. Home TW. Fibromuscular hyperplasia of the iliac arteries. Aust N Z J Surg. 1975;45:415-417.
91. Petitier H, DeLajartre AY, Geslin P, Godin JF, Victor J, Crochet D, Dupon H. Dysplasie fibreuse intimale coronaire et angor de Prinzmetal. Arch Mal Coeur Vaiss. 1978;71:1053-1059.
92. James TN. Morphologic characteristics and functional significance of focal fibromuscular dysplasia of small coronary arteries. Am J Cardiol. 1990;65:12G-22G.
93. James TN, Marshall TK. De subitaneis mortibus: XVII. Multi-focal stenoses due to fibromuscular dysplasia of the sinus node artery. Circulation. 1976;53:736-742.
94. James TN, Hackel DB, Marshall TK, De subitaneis mortibus: V. Occluded AV node artery. Circulation. 1974;49:772-777.
95. James TN, Riddick LR. Sudden death due to isolated acute infarction of the His bundle. J Am Coll Cardiol. 1990;15:1183-1187.
96. James TN, Marshall TK. De subitaneis mortibus: XII. Asymmetrical hypertrophy of the heart. Circulation. 1975;51:1149-1166.
97. Maron BJ, Ferrans VJ. Ultrastructural features of hypertrophied human ventricular myocardium. Prog Cardiovasc Dis. 1978;21: 207-238.
98. Wenzel RP. Molecular insights into hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1149-1152.
99. Watkins H, Rosenzweig A, Hwang D-S, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1108-1114.
100. Zheng LM, Zychlinsky A, Liu C-C, Ojcius DM, Young JD-E. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol. 1991;112:279-288.
101. James TN. An etiologic concept concerning the obscure myocardiopathies. Prog Cardiovasc Dis. 1964;7:43-64.
102. James TN, Cobbs BW, Coghlan HC, McCoy WC, Fisch C. Coronary disease, cardioneuropathy, and conduction system abnormalities in the cardiomyopathy of Friedreich's ataxia. Br Heart J. 1987;57:446-457.
103. James TN. Small arteries of the heart: the 36th George E. Brown Memorial Lecture. Circulation. 1977;56:2-14.
104. Sole MJ, Liu P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol. 1993;22:99A-105A.
105. Kyu B-S, Matsumori A, Sato Y, Okada I, Chapman NM, Tracy S. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy. Circulation. 1992;86:522-530.
106. Gougeon M-L, Montagnier L. Apoptosis in AIDS. Science. 1993; 260:1269-1270.
107. McCabe MJ Jr, Orrenius S. Deletion and depletion: the involvement of viruses and environmental factors in T-lymphocyte apoptosis. Lab Invest. 1992;66:403-406.
108. White E. Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. Proc Soc Exp Biol Med. 1993; 204:30-39.
109. Tamaru Y, Miyawaki T, Iwai K, Tsuji T, Nibu R, Yachie A, Koizumi S, Taniguchi N. Absence of bcl-2 expression by activated CD45RO+ T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death. Blood. 1993;82:521-527.
110. Rao I, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A. 1992;89:7742-7746.
111. Obrador D, Ballester M, Carrió I, Augé JM, López CM, Bosch I, Martí V, Bordes R. Active myocardial damage without attending inflammatory response in dilated cardiomyopathy. J Am Coll Cardiol. 1993;21:1667-1671.
112. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y. Right ventricular dysplasia: a report of 24 adult cases. In: Just H, Schuster HP, eds. Myocarditis Cardiomyopathy. Berlin, Germany: Springer-Verlag; 1983:81-93.
113. Fontaine G. Arrhythmogenic right ventricular dysplasia. Br Heart J. 1993;70:293-294.
114. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129-133.
115. Blankenship DC, Hug G, Balko G, van der Bel-Kann J, Coith RL Jr, Engel PJ. Hemodynamic and myocyte mitochondrial ultrastructural abnormalities in arrhythmogenic right ventricular dysplasia. Am Heart J. 1993;126:989-995.
116. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J. 1959;58: 59-70.
117. Schwartz CJ, Gerrity RG. Anatomical pathology of sudden unexpected death. Circulation. 1975;52(suppl 3):III-18-III-26.
118. Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology. 1985;56:351-358.
119. Engler RL, Gottlieb RA, Burleson KO, Babior BM. Myocyte cell death by apoptosis during reperfusion. Circulation. 1993;88(suppl 1):I-5. Abstract.